Arterial and Venous Blood Clot Removal Technology Expands with New Partnership in China
HALLANDALE, FL, October 05, 2022 /24-7PressRelease/ — Shanghai Easy-Flow Medical Technology Co., Ltd., and Control Medical Technology, LLC announced a partnership to commercialize the Control Mechanical Thrombectomy platform in the People’s Republic of China.
The Control Mechanical Thrombectomy System has been used in thousands of procedures to remove blood clots from the peripheral, coronary, and neuro vasculature.
“We look forward to launching Control’s thrombectomy technology in China, which provides precise, efficient, and cost-effective solutions for patients and physicians in China,” said Zhenghua Miao, General Manager of Shanghai Easy-Flow Medical Technology, Co., Ltd., Shanghai China. “Blood clots occur in large and small arteries and veins. So, clinicians need a diverse set of tools to a wide variety of conditions. Control Medical addresses thrombectomy needs with peripheral & coronary catheters powered by a best-in-class single-use mechanical aspirator and/or electric pump.”
Coronary thrombectomy in the heart treats acute myocardial infarction (AMI); neurovascular thrombectomy in the brain treats acute ischemic stroke; and peripheral thrombectomy treats peripheral arterial disease (PAD), chronic total occlusion (CTO), deep vein thrombosis (DVT), pulmonary embolism (PE), hemodialysis access occlusions, and other conditions. Certain technologies and procedures remove more healthy blood than others creating a patient safety risk.
“Targeting, control, and reducing blood-loss is important when removing blood clots,” said Lawrence S. Kronick, co-Founder Control Medical Technology. “Control’s system includes peripheral and coronary thrombectomy catheters powered by a single-use mechanical aspirator or electric pump for improved precision and force with low-blood-loss. We are excited to partner with Shanghai Easy-Flow to commercialize the Control platform in China.”
About Shanghai Easy-Flow Medical Technology Co., Ltd., Shanghai, China
Shanghai Easy-Flow Medical Technology, Co., Ltd. is a medical device company dedicated to providing integrated minimally-invasive solutions for vascular diseases. Easy-Flow strives for continuous innovation based independent R&D and collaborative investment, driven by the goal to enable more physicians and patients accessible to innovative and cost-effective products.
About Control Medical Technology, LLC. Hallandale, Florida, USA
Control’s platform includes the FDA cleared Control 5 -11F Mechanical Thrombectomy System indicated for peripheral vasculature, the Control RX-LP Mechanical Thrombectomy System indicated for peripheral and coronary vasculature, and the Control Mechanical Aspirator indicated for peripheral or coronary vasculature plus use as a high-performance 250ml piston-syringe. The Control’s electric pump-based PULSE & PULSE Retriever Basket is under development and not for sale at this time. Control Medical Technology’s platform is protected by issued and pending patents www.AspirationMedical.com.
RM Global Partners LLC served as advisor to Control Medical Technology, LLC in connection with this transaction.
Control Medical Technology Media contact: Carmen Aguilara (954) 534-9345 [email protected].
For the original version of this press release, please visit 24-7PressRelease.com here